Knuff & CO LLC Dexcom Inc Transaction History

Knuff & CO LLC

$306 Million
Q2 2024

A detailed history of Knuff & CO LLC transactions in Dexcom Inc stock. As of the latest transaction made, Knuff & CO LLC holds 30,318 shares of DXCM stock, worth $1.99 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

30,318

Previous 33,256 8.83%

Holding current value

$1.99 Million

Previous $4.61 Million 25.48%

% of portfolio

1.12%

Previous 1.56%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$110.31 - $140.45 $324,090 - $412,642	-2,938 Reduced 8.83%	30,318 $3.44 Million
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $91,376 - $112,080	-800 Reduced 2.35%	33,256 $4.61 Million
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $39,405 - $64,811	-522 Reduced 1.51%	34,056 $4.23 Million
Q3 2023 Nov 09, 2023	BUY	$86.06 - $137.93 $3,528 - $5,655	41 Added 0.12%	34,578 $3.23 Million
Q2 2023 Aug 08, 2023	SELL	$112.47 - $130.98 $18,557 - $21,611	-165 Reduced 0.48%	34,537 $4.44 Million
Q1 2023 May 08, 2023	SELL	$104.0 - $122.92 $67,704 - $80,020	-651 Reduced 1.84%	34,702 $4.03 Million
Q4 2022 Feb 09, 2023	BUY	$84.98 - $122.67 $9,092 - $13,125	107 Added 0.3%	35,353 $4 Million
Q3 2022 Nov 04, 2022	SELL	$76.35 - $94.18 $1.13 Million - $1.39 Million	-14,782 Reduced 29.55%	35,246 $2.84 Million
Q2 2022 Aug 08, 2022	BUY	$67.99 - $132.89 $2.53 Million - $4.95 Million	37,250 Added 291.52%	50,028 $3.73 Million
Q1 2022 May 10, 2022	SELL	$94.08 - $130.2 $14,864 - $20,571	-158 Reduced 1.22%	12,778 $6.54 Million
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $28,701 - $35,983	-221 Reduced 1.68%	12,936 $6.95 Million
Q3 2021 Nov 16, 2021	SELL	$106.71 - $143.18 $48,232 - $64,717	-452 Reduced 3.32%	13,157 $7.2 Million
Q2 2021 Aug 10, 2021	SELL	$80.99 - $107.93 $323 - $431	-4 Reduced 0.03%	13,609 $5.81 Million
Q1 2021 May 04, 2021	SELL	$84.79 - $104.74 $81,059 - $100,131	-956 Reduced 6.56%	13,613 $4.89 Million
Q4 2020 Feb 03, 2021	BUY	$78.0 - $104.5 $315,354 - $422,493	4,043 Added 38.41%	14,569 $5.39 Million
Q3 2020 Nov 03, 2020	SELL	$95.51 - $112.95 $7,354 - $8,697	-77 Reduced 0.73%	10,526 $4.34 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $141,092 - $237,120	2,251 Added 26.95%	10,603 $4.3 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $46,929 - $74,268	982 Added 13.32%	8,352 $2.25 Million
Q4 2019 Feb 11, 2020	BUY	$36.62 - $57.29 $4,577 - $7,161	125 Added 1.73%	7,370 $1.61 Million
Q3 2019 Nov 05, 2019	BUY	$35.53 - $43.8 $15,917 - $19,622	448 Added 6.59%	7,245 $1.08 Million
Q2 2019 Aug 08, 2019	BUY	$27.84 - $38.92 $14,198 - $19,849	510 Added 8.11%	6,797 $1.02 Million
Q1 2019 May 08, 2019	BUY	$28.07 - $38.18 $58,245 - $79,223	2,075 Added 49.26%	6,287 $749,000
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $113,681 - $157,402	4,212 New	4,212 $505,000

Others Institutions Holding DXCM

# of Institutions

1,112

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knuff & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knuff & CO LLC with notifications on news.

Account